On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

NEW YORK, Jan. 30, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global genomics market size is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio.

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...

Genomics involves the study of genes and genomes on a molecular level. Growing use of gene therapies and advancements in genomic technologies are forecasted to augment market growth. High investments ...

10x Genomics sees its Relative Strength Rating enter the elite 90-plus level.

Delray Beach, FL, March 19, 2026 (GLOBE NEWSWIRE)-- The genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, registering a CAGR of 12.6% from 2025 to 2030.

PUNE, INDIA, May 2, 2023 /EINPresswire.com/ -- The genomics market refers to the global market for products and services related to the study of genomes, including ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics ...

Analyst Daniel Brennan of TD Cowen maintained a Hold rating on 10x Genomics (TXG – Research Report), retaining the price target of $18.00. Daniel Brennan has given his Hold rating due to a combination ...

(MENAFN- GlobeNewsWire - Nasdaq) Advancements in NGS, AI-driven bioinformatics, and expanding precision medicine initiatives are positioning genomics as a strategic pillar in modern healthcare, ...